The trademark application MYTAGRY was filed by AstraZeneca UK Limited, a corporation established under the laws of the United Kingdom of Great Britain and Northern Ireland (the "Applicant"). The application was published for oppositions on January 31, 2023, and it was registered by office on May 10, 2023 without any oppositions.
The application was filed in English (German was selected as the second language).